Figure 1From: Successful use of pazopanib for treatment of refractory metastatic hemangiopericytomaResponse to pazopanib therapy in case 1. a. PET-CT at baseline and after 3 months of pazopanib treatment. b. Chest radiograph at baseline and after 4.5 months of pazopanib treatment.Back to article page